A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China

NCT06346899 · clinicaltrials.gov ↗

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema (HAE)

Interventions

OTHER: No intervention

Sponsor

Takeda